Despite recent progress, most notably with antisense oligonucleotides such as tofersen, which effectively reduce the synthesis of the SOD1 protein, no therapy capable of halting or reversing ALS progression has been developed. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.